Anna Caliò
Impact in
-
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Renal cell carcinoma treatment 35
- Lung Cancer Treatments and Mutations 9
-
- Renal and related cancers 29
- Co-authors
- Matteo Brunelli (43 shared papers)Guido Martignoni (39 shared papers)Diego Segala (10 shared papers)Marco Chilosi (10 shared papers)Giampaolo Tortora (11 shared papers)Emilio Bria (11 shared papers)Sara Pilotto (12 shared papers)Aldo Scarpa (10 shared papers)
- Journals
- Modern Pathology (9 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (8 papers)Pathology (4 papers)The American Journal of Surgical Pathology (4 papers)Cancers (3 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Anna Caliò
70 papers receiving 1.5k citations
Anna Caliò's Hit Papers
Peers
Comparison fields: 5 of 69
- Pulmonary and Respiratory Medicine 727
- Oncology 508
- Cancer Research 233
- Immunology 160
- Physiology 167
Countries citing papers authored by Anna Caliò
This map shows the geographic impact of Anna Caliò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Caliò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Caliò more than expected).
Fields of papers citing papers by Anna Caliò
This network shows the impact of papers produced by Anna Caliò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Caliò. The network helps show where Anna Caliò may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Caliò, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers Hit paper breakdown → | 2015 | 375 |
| 2 | 2019 | 94 | |
| 3 | 2016 | 60 | |
| 4 | 2017 | 48 | |
| 5 | 2018 | 46 | |
| 6 | 2014 | 46 | |
| 7 | 2019 | 41 | |
| 8 | 2020 | 41 | |
| 9 | 2016 | 40 | |
| 10 | 2013 | 35 | |
| 11 | 2012 | 35 | |
| 12 | 2014 | 35 | |
| 13 | 2018 | 33 | |
| 14 | 2015 | 32 | |
| 15 | 2018 | 32 | |
| 16 | 2021 | 32 | |
| 17 | 2021 | 30 | |
| 18 | 2020 | 30 | |
| 19 | 2023 | 27 | |
| 20 | 2022 | 25 |
About Anna Caliò
Anna Caliò is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Physiology and Cancer Research, having authored 76 papers that have together received 1.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (35 papers), Renal and related cancers (29 papers), Cancer Genomics and Diagnostics (13 papers), Tuberous Sclerosis Complex Research (13 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Vascular Tumors and Angiosarcomas (5 papers) and Histiocytic Disorders and Treatments (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (727 citations), Oncology (508 citations), Cancer Research (233 citations), Immunology (160 citations) and Physiology (167 citations). Anna Caliò has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Matteo Brunelli, Guido Martignoni, Diego Segala, Marco Chilosi, Giampaolo Tortora, Emilio Bria, Sara Pilotto, Aldo Scarpa, Serena Pedron and Luisa Carbognin. Their work appears in journals such as Modern Pathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Pathology, The American Journal of Surgical Pathology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.